Home  >  Products  >  BCL7A (B-cell CLL/lymphoma 7A) Blocking Peptide (the middle region of BCL7A)(100ug)
BCL7A (B-cell CLL/lymphoma 7A) Blocking Peptide (the middle region of BCL7A)(100ug)

BCL7A (B-cell CLL/lymphoma 7A) Blocking Peptide (the middle region of BCL7A)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-BCL7A Antibody(ARP57508_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP57508
Size: 100ug
Weight: 25kDa
Gene: 605
Format: Lyophilized powder
Target: This gene is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C. Two transcript variants encoding different isoforms have been found for this gene.
Alternative names: BCL7
See Full Product Listings >